Technology Roundup – Amazon upgraded at China Renaissance, Intel acquires machine learning platform Cnvrg.io Technology
Healthcare Roundup – Canopy Growth switches listing to Nasdaq, Brazil on board with resumption of J&J COVID-19 vaccine study Life Science
Technology Roundup – AT&T exploring sale of minority stake in pay TV operations; Uber, Lyft shares rally Technology
Applying in-house AI to Retail, Health Security and Workplace Safety | Remark Holdings (NASDAQ: MARK) Technology
Nov. 5, 2020 – Diversified Investing Strategies Agenda Live – Life Science, Fintech, Clean Tech Sectors Covered! Cannabis, Energy, Life Science, Technology
Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx Life Science
Technology Roundup – Twitter’s Dorsey says eroding Section 230 could ‘collapse’ Internet communication; Facebook’s Zuckerberg says Section 230 is important but needs update Technology
Healthcare Roundup – Lilly ends COVID-19 antibody trial, Moderna inks COVID-19 vaccine supply deal in Qatar Life Science
Technology Roundup – Strong demand prompts Ant Group to close order book early, Google antitrust case has status hearing set for Friday Technology
Healthcare Roundup – FDA getting cold feet on EUA nod for COVID-19 vaccines, AstraZeneca COVID-19 deal allows 20% gross profit Life Science
Technology Roundup – Judge won’t let U.S. block Tencent’s WeChat during appeal process, Facebook tries to shut down NYU political ad study Technology
Technology Roundup – IBM, Alibaba, and Huawei sign on to help Saudi Arabia’s AI push; IBM, Pfizer design AI model that can predict Alzheimer’s in seemingly healthy patients Technology
Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine Life Science
Healthcare Roundup – J&J’s daratumumab extends survival in first-line multiple myeloma, Death reported in Brazil study of AstraZeneca COVID-19 vaccine Life Science
Technology Roundup – Chinese tech firms flag concerns about Nvidia’s Arm deal, Jack Ma’s Ant Group gets Chinese approval for Shanghai arm of $35B IPO Technology
